A "hajas" sejtes leukaemiáról: saját tapasztalatok (1977-1998).

Translated title of the contribution: Hairy cell leukemia: authors' own experience (1977-1998)

B. Telek, A. Kiss, G. Ujj, L. Rejtó, J. Kappelmayer, P. Batár, Z. Nemes, K. Rák

Research output: Contribution to journalArticle

Abstract

Hairy cell leukaemia (HCL) is a rare, clinically and haematologically well characterised entity. The prognosis of patients with hairy cell leukaemia has significantly improved due to the new therapeutic approaches. Development of diagnostic and therapeutic methods, together with the analysis of their own hairy cell leukaemia patients, is reviewed by the authors. Between 1977 and 1998 twenty five patients (16 male, 9 female) were treated. The malignant cells were usually analysed by morphological and cytochemical methods and recently flow cytometric analysis could be performed in eight patients. Splenectomy with lethal outcome in six patients was performed in 21 cases. Approximately one third of patients received interferon, while 2-chlorodeoxyadenosine was given only to three patients. Favourable experiences obtained by splenectomy and efficacy of interferon treatment are emphasised, but according to the literature and their own results administration of purine analogues can be highly recommended in the future.

Original languageHungarian
Pages (from-to)987-991
Number of pages5
JournalOrvosi Hetilap
Volume140
Issue number18
Publication statusPublished - May 2 1999

Fingerprint

Hairy Cell Leukemia
Splenectomy
Interferons
Cladribine
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Telek, B., Kiss, A., Ujj, G., Rejtó, L., Kappelmayer, J., Batár, P., ... Rák, K. (1999). A "hajas" sejtes leukaemiáról: saját tapasztalatok (1977-1998). Orvosi Hetilap, 140(18), 987-991.

A "hajas" sejtes leukaemiáról : saját tapasztalatok (1977-1998). / Telek, B.; Kiss, A.; Ujj, G.; Rejtó, L.; Kappelmayer, J.; Batár, P.; Nemes, Z.; Rák, K.

In: Orvosi Hetilap, Vol. 140, No. 18, 02.05.1999, p. 987-991.

Research output: Contribution to journalArticle

Telek, B, Kiss, A, Ujj, G, Rejtó, L, Kappelmayer, J, Batár, P, Nemes, Z & Rák, K 1999, 'A "hajas" sejtes leukaemiáról: saját tapasztalatok (1977-1998).', Orvosi Hetilap, vol. 140, no. 18, pp. 987-991.
Telek B, Kiss A, Ujj G, Rejtó L, Kappelmayer J, Batár P et al. A "hajas" sejtes leukaemiáról: saját tapasztalatok (1977-1998). Orvosi Hetilap. 1999 May 2;140(18):987-991.
Telek, B. ; Kiss, A. ; Ujj, G. ; Rejtó, L. ; Kappelmayer, J. ; Batár, P. ; Nemes, Z. ; Rák, K. / A "hajas" sejtes leukaemiáról : saját tapasztalatok (1977-1998). In: Orvosi Hetilap. 1999 ; Vol. 140, No. 18. pp. 987-991.
@article{38e78162dd3a4689964ab0de906914cc,
title = "A {"}hajas{"} sejtes leukaemi{\'a}r{\'o}l: saj{\'a}t tapasztalatok (1977-1998).",
abstract = "Hairy cell leukaemia (HCL) is a rare, clinically and haematologically well characterised entity. The prognosis of patients with hairy cell leukaemia has significantly improved due to the new therapeutic approaches. Development of diagnostic and therapeutic methods, together with the analysis of their own hairy cell leukaemia patients, is reviewed by the authors. Between 1977 and 1998 twenty five patients (16 male, 9 female) were treated. The malignant cells were usually analysed by morphological and cytochemical methods and recently flow cytometric analysis could be performed in eight patients. Splenectomy with lethal outcome in six patients was performed in 21 cases. Approximately one third of patients received interferon, while 2-chlorodeoxyadenosine was given only to three patients. Favourable experiences obtained by splenectomy and efficacy of interferon treatment are emphasised, but according to the literature and their own results administration of purine analogues can be highly recommended in the future.",
author = "B. Telek and A. Kiss and G. Ujj and L. Rejt{\'o} and J. Kappelmayer and P. Bat{\'a}r and Z. Nemes and K. R{\'a}k",
year = "1999",
month = "5",
day = "2",
language = "Hungarian",
volume = "140",
pages = "987--991",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "18",

}

TY - JOUR

T1 - A "hajas" sejtes leukaemiáról

T2 - saját tapasztalatok (1977-1998).

AU - Telek, B.

AU - Kiss, A.

AU - Ujj, G.

AU - Rejtó, L.

AU - Kappelmayer, J.

AU - Batár, P.

AU - Nemes, Z.

AU - Rák, K.

PY - 1999/5/2

Y1 - 1999/5/2

N2 - Hairy cell leukaemia (HCL) is a rare, clinically and haematologically well characterised entity. The prognosis of patients with hairy cell leukaemia has significantly improved due to the new therapeutic approaches. Development of diagnostic and therapeutic methods, together with the analysis of their own hairy cell leukaemia patients, is reviewed by the authors. Between 1977 and 1998 twenty five patients (16 male, 9 female) were treated. The malignant cells were usually analysed by morphological and cytochemical methods and recently flow cytometric analysis could be performed in eight patients. Splenectomy with lethal outcome in six patients was performed in 21 cases. Approximately one third of patients received interferon, while 2-chlorodeoxyadenosine was given only to three patients. Favourable experiences obtained by splenectomy and efficacy of interferon treatment are emphasised, but according to the literature and their own results administration of purine analogues can be highly recommended in the future.

AB - Hairy cell leukaemia (HCL) is a rare, clinically and haematologically well characterised entity. The prognosis of patients with hairy cell leukaemia has significantly improved due to the new therapeutic approaches. Development of diagnostic and therapeutic methods, together with the analysis of their own hairy cell leukaemia patients, is reviewed by the authors. Between 1977 and 1998 twenty five patients (16 male, 9 female) were treated. The malignant cells were usually analysed by morphological and cytochemical methods and recently flow cytometric analysis could be performed in eight patients. Splenectomy with lethal outcome in six patients was performed in 21 cases. Approximately one third of patients received interferon, while 2-chlorodeoxyadenosine was given only to three patients. Favourable experiences obtained by splenectomy and efficacy of interferon treatment are emphasised, but according to the literature and their own results administration of purine analogues can be highly recommended in the future.

UR - http://www.scopus.com/inward/record.url?scp=0033516015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033516015&partnerID=8YFLogxK

M3 - Article

C2 - 10349322

AN - SCOPUS:0033516015

VL - 140

SP - 987

EP - 991

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 18

ER -